Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login

  Article Access Statistics

Year : 2017 | Volume:  13 | Issue Number:  3 | Page:  510-513

ORIGINAL ARTICLE

Docetaxel plus cisplatin plus fluorouracil versus carboplatin plus fluorouracil-cetuximab in first-line setting in patients with recurrent or metastatic head and neck squamous cell cancer who did not previously receive neoadjuvant or adjuvant chemotherapy, which is standard?
Mutlu Hasan, Salim Derya Kıvrak, Gündüz Şeyda, Eryılmaz Melek Karakurt, Musri Fatma Yalçın, Coşkun Hasan Şenol

Number of times this article was viewed 1735
Number of times this article has been printed  from the site 64
Number of times this article was emailed to others 0
Remarks given by readers [ Read ] 0
Back To Article

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal